Breakthrough Cancer Pain
medical animation

MoA video for a U.S. product launch of a breakthrough oncology drug.

Description
This 3D mechanism-of-action animation has been created for the U.S. product launch of Abstral® (fentanyl) Sublingual Tablets, the treatment for Breakthrough Cancer Pain (BTcP).

We began the video with the introduction of the cause of pain; highlighting metastatic bone cancer, before showcasing the mechanism of action (MOA) of the drug and its significant effect on breakthrough cancer pain.

  • Client

    Galena Biopharma

  • Brand

    Abstral®

  • Deliverables

    3D animation
    Product shots
    high-resolution images

The video is fantastic! It looks great! We appreciate the effort to get this in time for our conference.

Galena Biopharma | OREGON, USA


breakthrough cancer pain animation

What is Breakthrough Cancer Pain

1Breakthrough cancer pain (BTcP) is defined as a transient exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain.

Breakthrough cancer pain occurs in the majority of patients who are already receiving chronic, long-acting opioid pain management and yet have episodes of severe tumor- and treatment-related cancer pain.

reference: 1galenabiopharma.com

Related Work

Need Help With A Project?

Get in Touch